Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (5): 971-974. doi: 10.19723/j.issn.1671-167X.2020.05.030

Previous Articles     Next Articles

Concordant point mutation of ETS-related gene (ERG) in tumor tissues from a synchronous multiple primary lung cancer: A case report

Yi BAO1,2,∆(),Juan-fen MO2   

  1. 1. Department of Oncology, The Second Hospital of Jiaxing, Jiaxing 314000, Zhejiang, China
    2. Key Laboratory, The Second Hospital of Jiaxing, Jiaxing 314000, Zhejiang, China
  • Received:2018-10-16 Online:2020-10-18 Published:2020-10-15
  • Contact: Yi BAO E-mail:ybao2011@gmail.com
  • Supported by:
    Science and Technology Bureau of Jiaxing(2016AY23054);Health Bureau of Zhejiang Province(2016KYB292)

RICH HTML

 7   

PDF (PC)

495

Abstract:

The rearrangement of the gene encoding the transcription factor ETS-related gene (ERG) is thought to play a key role in the development of prostate cancer. However, the studies on the ERG mutations have been rarely reported in non-small cell lung carcinoma (NSCLC). Here, we reported genetic features regarding a case of a 68-year-old male patient who presented the primary synchronous multiple tumor lesions in the separated lungs. The patient was hospitalized due to the presence of tumor lesions at the right and left lungs revealed by a chest computerized tomography (CT) scan. After conducting lobectomies at the both lungs, the tumor nodules were all removed, and the histological analysis suggested adenocarcinoma at the both tumor lesions. The patient was diagnosed with synchronous multiple primary lung cancer (SMPLC) based on Martini-Melamed criteria and American College of Chest Physicians practice guidelines. An exome analysis of 315 genes in the two tumor lesions and a non-tumor lesion was conducted by using Illumina Nextseq500 platform from each tumor region to decipher a potential evolutional progress of SMPLC. Single or pair-end reads were first mapped to a human genome reference and filtered based on the mapping quality score. The read depth was ≥ 1 000× and the depth of coverage was 95%. The data revealed a discordant epidermal growth factor receptor (EGFR) from the separate lungs; additionally, a high frequency of point mutation on exon 9 H310P of the ERG gene was detected at the both sites of the tumor lesions. This case showed that a potential role of the molecular features analysis from each tumor lesion might contribute to the understanding of the evolutional development of SMPLC. This study suggests that the same environment may contribute certain gene(s) mutations in the same sites in the early stages of polyclonal tumor origins; meanwhile the extensive studies on these genes may help us understand the evolution and progress of tumor clones.

Key words: Lung neoplasms, Neoplasms, multiple primary, ETS-related gene, Mutation, High-throughput nucleotide sequencing

CLC Number: 

  • R734.2

Figure 1

The images of chest computed tomography (CT) before surgeries A, the arrow showed a size of 2.0 cm×2.0 cm lesion with irregular high density shadow at the upper lobe of right lung; B, the arrow showed a size of 1.4 cm×3.3 cm with ground glass nodule in the bottom lobe of left lung. "

Table 1

Comparison of somatic cell gene mutation with mutaton frequency ≥5% between the two separate tumor lesions"

Items Tumor nodule Gene Chromosome location Gene mutation Density Mutation frequency
Discordant (≥5%) Left side EGFR 7p11.2 exon21,c.2573T>G,p.L858R 1 844 15%(290/1 884)
ACVR1B 12q13.13 exon2,c.106T>A,p.C36S 554 9%(48/554)
GRIN2A 16p13.2 exon11,c.2326G>A,p.D776N 647 9% (56/647)
ATR 3q23 exon47,c.7912C>T,p.L2638F 483 7% (32/483)
EGFR 7p11.2 exon19,c.2240T>C,p.L747S 2 906 7% (207/2 906)
CBFR 16q22.1 exon5,c.481C>T,p.R161W 951 5% (48/951)
NF1 17q11.2 exon33,c.4462C>T,p.R1488C 775 5% (35/775)
NOTCH2 1p12 exon34,c.7153A>C,p.T2385P 914 5% (44/914)
Right side ARID2 12q12 exon5,c.539G>A,p.C180Y 588 6%(34/588)
ARID2 12q12 exon15,c.1960C>G,p.P654A 1 058 5% (48/1 058)
Concordant(≥5%) Left side ERG 21q22.2 exon9,c.929A>C,p.H310P 637 9% (60/637)
Right side ERG 21q22.2 exon9,c.929A>C,p.H310P 929 8% (74/929)

Figure 2

The mutation of ERG was analyzed from the TCGA non-small-cell lung carcinoma samples by using the cBioportal data analysis platform"

Figure 3

The correlation of ERG mutation and overall survival was analyzed from the TCGA non-small-cell lung carcinoma samples by using the cBioportal data analysis platform"

[1] Kumar-Sinha C, Tomlins SA, Chinnaiyan AM. Recurrent gene fusions in prostate cancer[J]. Nat Rev Cancer, 2008,8(7):497-511.
doi: 10.1038/nrc2402 pmid: 18563191
[2] Brenner JC, Ateeq B, Li Y, et al. Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer[J]. Cancer Cell, 2011,19(5):664-678.
doi: 10.1016/j.ccr.2011.04.010
[3] Wang X, Qiao Y, Asangani IA, et al. Development of peptidomimetic inhibitors of the ERG gene gusion product in prostate cancer[J]. Cancer Cell, 2017,31(4):532-548.
doi: 10.1016/j.ccell.2017.02.017 pmid: 28344039
[4] Martini N, Melamed MR. Multiple primary lung cancers[J]. J Thorac Cardiovasc Surg, 1975,70(4):606-612.
pmid: 170482
[5] Kozower BD, Larner JM, Detterbeck FC. Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines[J]. Chest, 2013,143(5 Suppl):e369S-e399S.
doi: 10.1378/chest.12-2362 pmid: 23649447
[6] Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin[J]. Cancer, 1953,6(5):963-968.
doi: 10.1002/1097-0142(195309)6:5<963::aid-cncr2820060515>3.0.co;2-q pmid: 13094644
[7] Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma[J]. Nature, 2014,511(7511):543-550.
doi: 10.1038/nature13385
[8] Jamal-Hanjani M, Wilson GA, McGranahan N, et al. Tracking the evolution of non-small-cell lung cancer[J]. N Engl J Med, 2017,376(22):2109-2121.
doi: 10.1056/NEJMoa1616288 pmid: 28445112
[9] Adamo P, Ladomery MR. The oncogene ERG: A key factor in prostate cancer[J]. Oncogene, 2016,35(4):403-414.
doi: 10.1038/onc.2015.109 pmid: 25915839
[10] Ida K, Kobayashi S, Taki T, et al. EWS-FLI-1 and EWS-ERG chimeric mRNAs in Ewing’s sarcoma and primitive neuroectodermal tumor[J]. Int J Cancer, 1995,63(4):500-504.
doi: 10.1002/ijc.2910630407 pmid: 7591257
[11] Nagai N, Ohguchi H, Nakaki R, et al. Downregulation of ERG and FLI1 expression in endothelial cells triggers endothelial-to-mesenchymal transition[J]. PLoS Genet, 2018,14(11):e1007826.
doi: 10.1371/journal.pgen.1007826 pmid: 30500808
[1] Zhan-yue NIU,Yan XUE,Jing ZHANG,He-jun ZHANG,Shi-gang DING. Analysis of endoscopic and pathological features of gastric adenomatous polyps and risk factors for canceration [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1122-1127.
[2] Jian-fei YE,Lei ZHAO,Guo-liang WANG,Kai HONG,Lu-lin MA. Clinical analysis of testicular rhabdomyosarcoma [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1178-1182.
[3] FENG Ke,NI Jing-jing,XIA Yan-qing,QU Xiao-wei,ZHANG Hui-juan,WAN Feng,HONG Kai,ZHANG Cui-lian,GUO Hai-bin. Genetic analysis of three cases of acephalic spermatozoa syndrome caused by SUN5 mutation and the outcome of assisted reproductive technology [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 803-807.
[4] KANG Wen-yu,WANG Lu,QIU Min,ZHANG Fan,GUO Wei,QIANG Ya-yong,TUO Peng-fei,ZONG You-long,LIU Lei-lei,WANG Shuai-shuai. Adrenal cavernous hemangioma: A case report and literature review [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 808-810.
[5] LIN Guo-zhong, MA Chang-cheng, WANG Zhen-yu, XIE Jing-cheng, LIU Bin, CHEN Xiao-dong. Minimally invasive treatment of cervical1-2 epidural neurilemmoma [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 586-589.
[6] LI Xin-fei, PENG Yi-ji, YU Xiao-teng, XIONG Sheng-wei, CHENG Si-da, DING Guang-pu, YANG Kun-lin, TANG Qi, MI Yue, WU Jing-yun, ZHANG Peng, XIE Jia-xin, HAO Han, WANG He, QIU Jian-xing, YANG Jian, LI Xue-song, ZHOU Li-qun. Three dimensional nephrometry system for partial nephrectomy: Our initial exploration [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 613-622.
[7] CHEN Huai-an,LIU Shuo,LI Xiu-jun,WANG Zhe,ZHANG Chao,LI Feng-qi,MIAO Wen-long. Clinical value of inflammatory biomarkers in predicting prognosis of patients with ureteral urothelial carcinoma [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 302-307.
[8] LIAO Xu-he,WANG Rong-fu,LIU Meng,CHEN Xue-qi,XIONG Yan,NONG Lin,YIN Lei,ZHANG Bing-ye,DU Yu-jing. Semiquantitative parameters of 18F-FDG PET/CT, gene mutation states of epidermal growth factor receptor and anaplastic lymphoma kinase in prognosis evaluation of patients with lung adenocarcinoma [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 246-254.
[9] CAO Ze,WANG Le-tong,LIU Zhen-ming. Homologous modeling and binding ability analysis of Spike protein after point mutation of severe acute respiratory syndrome coronavirus 2 to receptor proteins and potential antiviral drugs [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 150-158.
[10] YUAN Yuan,LANG Ning,YUAN Hui-shu. CT spectral curve in differentiating spinal tumor metastasis and infections [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 183-187.
[11] WU Jun-yi,YU Miao,SUN Shi-chen,FAN Zhuang-zhuang,ZHENG Jing-lei,ZHANG Liu-tao,FENG Hai-lan,LIU Yang,HAN Dong. Detection of EDA gene mutation and phenotypic analysis in patients with hypohidrotic ectodermal dysplasia [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 24-33.
[12] Ying-chao WU,Yun-long CAI,Long RONG,Ji-xin ZHANG,Jin LIU,Xin WANG. Characteristics of lymph node metastasis and evaluating the efficacy of endoscopic submucosal dissection in early gastric cancer [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1093-1097.
[13] Huan-bin YU,Wen-jie WU,Xiao-ming LV,Yan SHI,Lei ZHENG,Jian-guo ZHANG. 125I seed brachytherapy for recurrent salivary gland carcinoma after external radiotherapy [J]. Journal of Peking University (Health Sciences), 2020, 52(5): 919-923.
[14] Yi LIU,Zhi-jian LIU,Qi SHEN,Jing-yun WU,Yu FAN,De-run LI,Wei YU,Zhi-song HE. A clinical analysis of 14 cases of prostatic stromal tumor of uncertain malignant potential [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 621-624.
[15] Yi-chang HAO,Ye YAN,Fan ZHANG,Min QIU,Lang ZHOU,Ke LIU,Jian LU,Chun-lei XIAO,Yi HUANG,Cheng LIU,Lu-lin MA. Surgical strategy selection and experience summary of prostate cancer with positive single needle biopsy [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 625-631.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 456 -458 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 125 -128 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 135 -140 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 158 -161 .
[5] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 217 -220 .
[6] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 52 -55 .
[7] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 109 -111 .
[8] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 297 -301 .
[9] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 599 -601 .
[10] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 516 -520 .
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd